EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil

Debatrayee Dasgupta, Sonal Thakore, Anjali Patel, Sriram Seshadri

RSC Pharmaceutics · 2026 · 3 (3) · 738-748

DOI: 10.1039/d5pm00390c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Debatrayee Dasgupta und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work describes a biotin-targeted mesoporous silica nanocarrier that enables sequential and stimuli-responsive co-delivery of camptothecin as well as 5-fluorouracil for enhanced tumour suppression with reduced hepatic toxicity.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Dasgupta, D., Thakore, S., Patel, A., & Seshadri, S. (2026). In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil. RSC Pharmaceutics, 3(3), 738-748. https://doi.org/10.1039/d5pm00390c

Vancouver

Dasgupta D, Thakore S, Patel A, Seshadri S. In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil. RSC Pharmaceutics. 2026;3(3):738-748. doi:10.1039/d5pm00390c

BibTeX
@article{Dasgupta2026,
  author = {Dasgupta, Debatrayee and Thakore, Sonal and Patel, Anjali and Seshadri, Sriram},
  title = {In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil},
  journal = {RSC Pharmaceutics},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {738--748},
  doi = {10.1039/d5pm00390c}
}
Kostenlos starten →